COLUCCIA, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 6.208
AS - Asia 2.513
EU - Europa 1.645
SA - Sud America 652
AF - Africa 111
OC - Oceania 4
AN - Antartide 1
Totale 11.134
Nazione #
US - Stati Uniti d'America 6.137
SG - Singapore 1.000
CN - Cina 819
BR - Brasile 561
SE - Svezia 397
HK - Hong Kong 328
RU - Federazione Russa 259
IT - Italia 211
UA - Ucraina 206
DE - Germania 199
FI - Finlandia 142
VN - Vietnam 130
GB - Regno Unito 93
CI - Costa d'Avorio 80
IN - India 60
AR - Argentina 41
CA - Canada 34
ID - Indonesia 28
BD - Bangladesh 27
FR - Francia 27
MX - Messico 24
JP - Giappone 19
BE - Belgio 18
EC - Ecuador 17
ZA - Sudafrica 17
IE - Irlanda 16
TR - Turchia 16
ES - Italia 15
CZ - Repubblica Ceca 12
IQ - Iraq 12
IR - Iran 12
AT - Austria 10
CO - Colombia 10
JO - Giordania 10
PK - Pakistan 10
PL - Polonia 10
NL - Olanda 7
VE - Venezuela 7
PY - Paraguay 6
UZ - Uzbekistan 6
CL - Cile 5
LT - Lituania 5
SA - Arabia Saudita 5
TN - Tunisia 5
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
GE - Georgia 3
IL - Israele 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
KR - Corea 2
LB - Libano 2
MA - Marocco 2
OM - Oman 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
TH - Thailandia 1
UY - Uruguay 1
Totale 11.134
Città #
Fairfield 634
Chandler 602
Woodbridge 576
Ashburn 509
Jacksonville 461
Singapore 460
Houston 369
Nyköping 327
Hong Kong 326
Seattle 268
Ann Arbor 255
Cambridge 244
Wilmington 212
Beijing 211
Nanjing 141
Bari 132
Lawrence 128
Roxbury 128
New York 123
Boardman 87
Des Moines 84
Abidjan 80
Dallas 72
Los Angeles 72
Princeton 57
Inglewood 55
Ho Chi Minh City 54
Brooklyn 42
Nanchang 42
Buffalo 40
Hebei 39
São Paulo 39
Helsinki 38
Santa Clara 36
Shenyang 33
Jiaxing 32
San Diego 32
Dearborn 29
Hanoi 25
Munich 25
Council Bluffs 24
Pune 23
Guangzhou 19
Tianjin 19
Tokyo 19
San Francisco 18
Brussels 17
Moscow 17
Dublin 16
Jakarta 15
Rio de Janeiro 15
Shanghai 15
Belo Horizonte 14
Changsha 13
Columbus 13
The Dalles 13
Ardabil 12
Boston 12
Brasília 12
Toronto 12
Brno 11
London 11
Phoenix 11
Amman 10
Auburn Hills 10
Dong Ket 10
Johannesburg 10
Kunming 10
Leawood 10
Mumbai 10
Washington 10
Jinan 9
Montreal 9
Ningbo 9
Salvador 9
Wuhan 9
Chicago 8
San Mateo 8
Santo André 8
Zhengzhou 8
Augusta 7
Chennai 7
Curitiba 7
Quito 7
Redwood City 7
Ribeirão Preto 7
Stockholm 7
Warsaw 7
Wuxi 7
Ankara 6
Baghdad 6
Denver 6
Hefei 6
Jinhua 6
Norwalk 6
Paris 6
Porto Alegre 6
Taizhou 6
Tashkent 6
Turku 6
Totale 7.756
Nome #
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 187
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 162
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 162
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 160
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 158
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 158
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 155
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 150
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 144
Mutagenic activity of some platinum complexes: chemical properties and biological activity 141
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 141
Effect of chirality in platinum drugs 131
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 128
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 127
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 126
Biologic activity of platiunum complexes with proflavine 125
Endothelial cells in the bone marrow of patients with multiple myeloma 118
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 113
Platinum(II) based anticancer agents with a trans geometry 110
Antitumour platinum iminoether complexes 108
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 108
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 107
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 106
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 105
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 105
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 104
null 104
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 103
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 102
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 102
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 102
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 102
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 102
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 102
Antitumour ruthenium(II)-dimethylsulfoxide complexes 102
Antitumour platinum-iminoether complexes 101
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 101
Antitumour platinum iminoether complexes 100
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 100
Antitumor active trans-platinum compounds 98
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 97
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 97
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 97
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 94
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 94
In vitro cisplatin effects on phagocyte functions 93
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 92
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 91
null 91
Anttitumor activity of trans-platinum species 91
Antitumor activity of trans platinum complexes 91
Current Status of trans-Platinum Compounds in Cancer Therapy 91
Trans-Platinum Complexes in Cancer Therapy 90
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 90
null 88
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 86
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 85
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 84
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 84
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 83
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 82
Bone Marrow Fibroblasts and Multiple Myeloma Progression 81
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 80
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 78
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 78
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 76
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 76
Complessi antitumorali di platino a geometria trans 74
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 73
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 73
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 72
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 71
A trans-platinum complex showing higher antitumor activity than the cis congeners 71
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 70
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 70
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 70
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 69
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 69
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 69
null 68
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 67
null 67
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 66
null 66
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 65
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 65
null 65
null 65
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 64
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 64
Screening tests for selecting anticancer metal compounds 62
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 62
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 61
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 61
A new generation of platinum anticancer complexes with trans geometry 61
DNA interaction properties of platinum –iminoether complexes 60
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 59
Trans platinum complexes in cancer therapy: a largely unexplored strategy of identifying novel antitumour platinum drugs 58
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 58
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 58
Totale 9.393
Categoria #
all - tutte 46.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 65 75 90 156 177 123 55
2021/2022787 21 121 1 30 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/20251.919 138 30 183 64 46 132 206 137 54 94 294 541
2025/20262.120 564 172 335 486 490 73 0 0 0 0 0 0
Totale 11.441